Skip Navigation
Skip to contents

IMKASID 2024

Menu View
End Today : 2024-05-14
  • Twitter
Menu Close

Home

Program
Invited Speakers

Invited Speakers

검색

Day 2 – April 12 (Fri)

[Breakfast with Master 1] April 12 (Fri), 07:30-08:00 | Room C
  • Evolving IBD Care - A Deep Dive into Shingles Prevention for IBD Patients Shin Ju Oh Kyung Hee University
    Korea

Day 2 – April 12 (Fri)

[Breakfast with Master 2] April 12 (Fri), 07:30-08:00 | Meeting Room 1
  • Optimal Bowel Preparation for the Elderly Jae Myung Cha Kyung Hee University
    Korea

Day 2 – April 12 (Fri)

[Breakfast with Master 3] April 12 (Fri), 07:30-08:00 | Meeting Room 2
  • Mini-OSTs: A Warm Welcome to Bowel Preparation for Colonoscopy! Jaeyoung Chun Yonsei University
    Korea

Day 2 – April 12 (Fri)

[RAPID Forum] Clinical Challenges in Various Intestinal Diseases April 12 (Fri), 08:30-10:00 | Room A
  • IBD vs. IBD Mimickers: Clinical Pearls for Differential Diagnosis Julajak Limsrivilai Mahidol University
    Thailand
  • Old but Gold- Leveraging Conventional Immunosuppressants in the Biologics Era in IBD Patients Soo-Kyung Park Sungkyunkwan University
    Korea
  • Challenges in Diagnosis of Early Colorectal Cancer in Limited Resources Settings Hang Viet Dao Hanoi Medical University Hospital
    Vietnam
  • Optimal Approach for Suspected Small Intestinal Bleeding Seung Wook Hong University of Ulsan
    Korea

Day 2 – April 12 (Fri)

[KASID-KAI Joint Symposium] Immune Mediated Inflammatory Disorders (IMIDs): The Key to Advancing IBD Treatment and Fostering Collaborative Research (KOR) April 12 (Fri), 08:30-10:00 | Room B
  • The IMIDs Connection: Why IBD Doctors Need to Pay Attention? Seong-Joon Koh Seoul National University
    Korea
  • Shared Genetic Landscapes Between IBD and Other IMIDs Kwangwoo Kim National Institutes of Health
    USA
  • Role of Microbiota and Nutrients in Gut Immune Regulation Ye-Ji Bang Seoul National University
    Korea
  • The Microbiome as Pharmabiotics in IMIDs Ho-Keun Kwon Yonsei University
    Korea

Day 2 – April 12 (Fri)

[Symposium 1] Latest Advances in IBD Treatment April 12 (Fri), 10:20-11:50 | Room A
  • Keynote: Tailored Management of Difficult-to-Treat IBD Gil Y. Melmed Cedars-Sinai Medical Center
    USA
  • ‘Old’ and ‘New’ Biologics: New Insights Won Moon Kosin University
    Korea
  • The Era of Small Molecules: Good Things Come in Small Packages Katsuyoshi Matsuoka Toho University Sakura Medical Center
    Japan

Day 2 – April 12 (Fri)

[Symposium 2] How to Deal with Troublesome Situations in the Management of Colorectal Neoplasia April 12 (Fri), 10:20-11:50 | Room B
  • Keynote: Preventing Complications Following Endoscopic Resection: Here’s the Best Way to Do It Fatih Aslan Koc University
    Turkiye
  • Selecting Endoscopic Resection and Surveillance for T1 CRC: What is the Optimal Indication? Katsuro Ichimasa Showa University Northern Yokohama Hospital
    Japan
  • Tips and Tricks for Resecting Locally Recurrent Adenomas Jun Lee Chosun University
    Korea

Day 2 – April 12 (Fri)

[IMKASID for 'JUMP': Pathway for Rising Stars in Intestinal Research] First Steps as A Researcher April 12 (Fri), 10:20-11:50 | Room C
  • Summary of New Agents for IBD - Filgotinib Minjee Kim Sungkyunkwan University
    Korea
  • Summary of New Agents for IBD - Ozanimod Sang Hyun Kim Korea University
    Korea
  • Risk Factors for the Need of Salvage Treatment in Rectal Neuroendocrine Tumors with Positive Margin after Endoscopic Resection Hyung-Hoon Oh Chonnam National University
    Korea
  • Inflammatory Bowel Disease (IBD) in Pediatrics and Adults: Commonalities, Differences, Transition Donghwan Park Dongguk University Ilsan Hospital
    Korea
  • JAK Inhibitors in IBD: From Bench to Bedside Sang Un Kim Kyungpook National University Chilgok Hospital
    Korea
  • The Use of Clinical Decision Support Tools in the Treatment of Inflammatory Bowel Disease Kyuwon Kim Chung-Ang University
    Korea

Day 2 – April 12 (Fri)

[Luncheon Symposium 1] April 12 (Fri), 12:00-12:40 | Room A
  • Impact of Subcutaneous Infliximab in IBD Treatment Byong Duk Ye University of Ulsan
    Korea
  • Interim Analysis of Subcutaneous Infliximab Cohort Study in Korea Chang Hwan Choi Chung-Ang University
    Korea

Day 2 – April 12 (Fri)

[Luncheon Symposium 2] Durable Journey of Ustekinumab in IBD : Think ‘Long-term’ Outcomes April 12 (Fri), 12:40-13:20 | Room A
  • A Step Closer to Durable Remission with
    Ustekinumab for Patients in UC     Eun Soo Kim Kyungpook National University
    Korea
  • Long-term Strategy for Bio-naive CD Patients with Ustekinumab Hyuk Yoon Seoul National University
    Korea

Day 2 – April 12 (Fri)

[Luncheon Symposium 3] April 12 (Fri), 12:00-12:40 | Room B
  • Unveiling New Horizons in Crohn's Disease with Upadacitinib: The First Oral Advanced Therapy Jae Hee Cheon Yonsei University
    Korea
  • Upadacitinib in Focus: First Option for Achieving Mucosal Healing in UC Chang Kyun Lee Kyung Hee University
    Korea

Day 2 – April 12 (Fri)

[Luncheon Symposium 4] Discovering Optimal Approaches for Lifelong Care in CD April 12 (Fri), 12:40-13:20 | Room B
  • Optimal Approaches in CD : Who Can be the Right Patient for Vedolizumab? Parambir S Dulai Northwestern University Feinberg School of Medicine
    USA
  • Vedolizumab in Ileal and Colonic Crohn's Disease Sung Noh Hong Sungkyunkwan University
    Korea

Day 2 – April 12 (Fri)

[Luncheon Symposium 5] April 12 (Fri), 12:00-12:40 | Room C
  • The Latest Update in Management of IBD Jong Pil Im Seoul National University
    Korea
  • Extraintestinal Manifestation in IBD: Looking Beyond the Tract Ji Won Kim Seoul National University
    Korea

Day 2 – April 12 (Fri)

[Luncheon Symposium 6] April 12 (Fri), 12:40-13:20 | Room C
  • Management of Ulcerative Colitis (UC) Flare in Mild-moderate Patients Sung Wook Hwang University of Ulsan
    Korea
  • ASACOL 1,600mg, One Tablet Once Daily to Maintain Remission Dae Sung Kim Konyang University
    Korea

Day 2 – April 12 (Fri)

[KASID-WEO Joint Symposium] Future Directions in CRC Screening: What's Next? April 12 (Fri), 13:50-15:20 | Room A
  • Screening for Individuals Before 50: What Age Should We Start? Eun Hyo Jin Seoul National University
    Korea
  • Colonoscopy as the First-line Screening Test: Everything You Need to Know Uri Ladabaum Stanford University
    USA
  • Precision Medicine for Screening in the Near Future Han-Mo Chiu National Taiwan University Hospital
    Taiwan

Day 2 – April 12 (Fri)

[Symposium 3] Basic and Translational Research: A Deep Dive into the Mechanisms of IBD April 12 (Fri), 13:50-15:20 | Room B
  • Host-Microbial Interaction in IBD Jun Miyoshi Kyorin University
    Japan
  • Gut Barrier Dysfunction, Microbiome, and Environmental Factors in the Development of Crohn's Disease Williams Turpin Mount Sinai Hospital
    Canada
  • Defining the Role of FMT in IBD Moving Forward Rupert Leong University of Sydney
    Australia

Day 2 – April 12 (Fri)

[KASID-GEST Joint Symposium] Practical Strategies for Managing Difficult Clinical Scenarios in IBD April 12 (Fri), 13:50-15:20 | Room C
  • Infections in IBD: Prevention, Diagnosis, and Management Puo-Hsien Le Chang Gung Memorial Hospital
    Linkou branch, Taoyuan
  • Acute Severe Ulcerative Colitis: Integrating the Latest Evidence into Clinical Practice Eun Mi Song Ewha Womans University
    Korea
  • Multidisciplinary Approach to Intraabdominal Abscesses in Crohn’s Disease Yoo Jin Lee Keimyung University
    Korea
  • Endoscopic Management of Crohn’s Stricture: Timing, Techniques, and Outcomes Chen-Wang Chang MacKay Memorial Hospital
    Taiwan

Day 2 – April 12 (Fri)

[Symposium 4] MDT Case Discussion: Multidisciplinary Approach in Challenging Cases April 12 (Fri), 15:40-17:10 | Room A

Day 2 – April 12 (Fri)

[KASID-KSAR Joint Symposium] Bridging Specialties: Optimizing Diagnosis and Management through GI-Radiology Collaboration April 12 (Fri), 15:40-17:10 | Room C
  • Treat-to-Target of Small bowel CD: How to Deal with Capsule and Enteroscopy? Seong Ran Jeon Soonchunhyang University
    Korea
  • Defining Transmural Healing of Crohn's Disease: The Role of Cross-sectional Imaging Modalities Myung-Won You Kyung Hee University
    Korea
  • MRI for Staging Rectal Cancer: Current Role and Challenges in Clinical Practices Nieun Seo Yonsei University
    Korea
Diamond
  • abbvie
  • CELLTRION PHARM
  • Jassen
  • SAMSUNG BIOEPIS
  • Takeda
Platinum
  • Bristrol Myers Squibb
  • DEAWOONG
  • FERRING PHARMACEUTICALS
Gold
  • Eisasi Korea Inc.
  • Pfizer
Bronze
  • GSK
  • Pharmbio Korea Inc.
  • TAEJOON

Go Top

Korean Association for the Study of Intestinal Diseases
31, Seolleung-ro 86 Gil, Gangnam-Gu, Seoul, 06193, Korea
IMKASID 2024 Secretariat [People-x, Inc.]
  • 1F, Haeoreum B/D, 16, Yeoksam-ro 17-gil, Gangnam-gu, Seoul, 06246, Korea
    [All Inquiries] info@imkasid.kr
    [Scientific Program/Abstract] +82-2-566-5951
    [Registration] +82-70-4895-6139
    [Sponsorship] +82-70-4895-6110

Copyright ⓒ Korean Association for the Study of Intestinal Diseases All rights reserved